Skip to main content
. 2017 Feb 1;8(14):22483–22489. doi: 10.18632/oncotarget.14956

Figure 1.

Figure 1

Comparison of serum chemerin levels (A) between healthy controls and NSCLC patients; (B) in healthy controls and NSCLC patients at different TNM stage; (C) in NSCLC patients with and without lymph node metastasis; (D) in NSCLC patients with and without distant metastasis.